Solfarcos nears Phase 2a clinical trial for innovative methotrexate nanotechnology treatment of Rheumatoid Arthritis
BRAGA, PORTUGAL, January 27, 2026 /EINPresswire.com/ -- FBL-MTX — Solfarcos’ folate-targeted liposomal methotrexate shows promising clinical Phase 2a progress that may reshape rheumatoid arthritis management and support future expansion into …